186 related articles for article (PubMed ID: 35575798)
1. DPYSL2 interacts with JAK1 to mediate breast cancer cell migration.
Abu Rmaileh A; Solaimuthu B; Khatib A; Lavi S; Tanna M; Hayashi A; Ben Yosef M; Lichtenstein M; Pillar N; Shaul YD
J Cell Biol; 2022 Jul; 221(7):. PubMed ID: 35575798
[TBL] [Abstract][Full Text] [Related]
2. Coactivation of janus tyrosine kinase (Jak)1 positively modulates prolactin-Jak2 signaling in breast cancer: recruitment of ERK and signal transducer and activator of transcription (Stat)3 and enhancement of Akt and Stat5a/b pathways.
Neilson LM; Zhu J; Xie J; Malabarba MG; Sakamoto K; Wagner KU; Kirken RA; Rui H
Mol Endocrinol; 2007 Sep; 21(9):2218-32. PubMed ID: 17550976
[TBL] [Abstract][Full Text] [Related]
3. Syndecan-1 suppresses cell growth and migration via blocking JAK1/STAT3 and Ras/Raf/MEK/ERK pathways in human colorectal carcinoma cells.
Wang S; Zhang X; Wang G; Cao B; Yang H; Jin L; Cui M; Mao Y
BMC Cancer; 2019 Nov; 19(1):1160. PubMed ID: 31783811
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-520a-3p suppresses epithelial-mesenchymal transition, invasion, and migration of papillary thyroid carcinoma cells via the JAK1-mediated JAK/STAT signaling pathway.
Bi CL; Zhang YQ; Li B; Guo M; Fu YL
J Cell Physiol; 2019 Apr; 234(4):4054-4067. PubMed ID: 30206929
[TBL] [Abstract][Full Text] [Related]
5. Gremlin-1 Promotes Metastasis of Breast Cancer Cells by Activating STAT3-MMP13 Signaling Pathway.
Sung NJ; Kim NH; Surh YJ; Park SA
Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33287358
[TBL] [Abstract][Full Text] [Related]
6. Extract of
Huang X; Chen Y; Zhang X; Li F; Ye H
Cancer Biother Radiopharm; 2020 Oct; 35(8):586-595. PubMed ID: 32486841
[No Abstract] [Full Text] [Related]
7. Janus Kinase 1 Plays a Critical Role in Mammary Cancer Progression.
Wehde BL; Rädler PD; Shrestha H; Johnson SJ; Triplett AA; Wagner KU
Cell Rep; 2018 Nov; 25(8):2192-2207.e5. PubMed ID: 30463015
[TBL] [Abstract][Full Text] [Related]
8. Dysregulation of DPYSL2 expression by mTOR signaling in schizophrenia: Multi-level study of postmortem brain.
Izumi R; Hino M; Nagaoka A; Shishido R; Kakita A; Hoshino M; Kunii Y; Yabe H
Neurosci Res; 2022 Feb; 175():73-81. PubMed ID: 34543692
[TBL] [Abstract][Full Text] [Related]
9. CRMP2 is a therapeutic target that suppresses the aggressiveness of breast cancer cells by stabilizing RECK.
Lin B; Li Y; Wang T; Qiu Y; Chen Z; Zhao K; Lu N
Oncogene; 2020 Sep; 39(37):6024-6040. PubMed ID: 32778769
[TBL] [Abstract][Full Text] [Related]
10. Raf kinase inhibitor protein (RKIP) blocks signal transducer and activator of transcription 3 (STAT3) activation in breast and prostate cancer.
Yousuf S; Duan M; Moen EL; Cross-Knorr S; Brilliant K; Bonavida B; LaValle T; Yeung KC; Al-Mulla F; Chin E; Chatterjee D
PLoS One; 2014; 9(3):e92478. PubMed ID: 24658061
[TBL] [Abstract][Full Text] [Related]
11. miR-30e acts as a tumor suppressor in hepatocellular carcinoma partly via JAK1/STAT3 pathway.
Mao J; Hu X; Pang P; Zhou B; Li D; Shan H
Oncol Rep; 2017 Jul; 38(1):393-401. PubMed ID: 28560434
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA DANCR promotes nasopharyngeal carcinoma progression by interacting with STAT3, enhancing IL-6/JAK1/STAT3 signaling.
Zhang X; Yang J; Bian Z; Shi D; Cao Z
Biomed Pharmacother; 2019 May; 113():108713. PubMed ID: 30849642
[TBL] [Abstract][Full Text] [Related]
13. Berberine suppresses bladder cancer cell proliferation by inhibiting JAK1-STAT3 signaling via upregulation of miR-17-5p.
Xia Y; Chen S; Cui J; Wang Y; Liu X; Shen Y; Gong L; Jiang X; Wang W; Zhu Y; Sun S; Li J; Zou Y; Shi B
Biochem Pharmacol; 2021 Jun; 188():114575. PubMed ID: 33887260
[TBL] [Abstract][Full Text] [Related]
14. IL20RA signaling enhances stemness and promotes the formation of an immunosuppressive microenvironment in breast cancer.
Gao W; Wen H; Liang L; Dong X; Du R; Zhou W; Zhang X; Zhang C; Xiang R; Li N
Theranostics; 2021; 11(6):2564-2580. PubMed ID: 33456560
[No Abstract] [Full Text] [Related]
15. LIF-JAK1-STAT3 signaling delays contact inhibition of human corneal endothelial cells.
Liu X; Tseng SC; Zhang MC; Chen SY; Tighe S; Lu WJ; Zhu YT
Cell Cycle; 2015; 14(8):1197-206. PubMed ID: 25695744
[TBL] [Abstract][Full Text] [Related]
16. Targeting JAK1/STAT3 signaling suppresses tumor progression and metastasis in a peritoneal model of human ovarian cancer.
Wen W; Liang W; Wu J; Kowolik CM; Buettner R; Scuto A; Hsieh MY; Hong H; Brown CE; Forman SJ; Horne D; Morgan R; Wakabayashi M; Dellinger TH; Han ES; Yim JH; Jove R
Mol Cancer Ther; 2014 Dec; 13(12):3037-48. PubMed ID: 25319391
[TBL] [Abstract][Full Text] [Related]
17. Leukemia inhibitory factor regulates trophoblast giant cell differentiation via Janus kinase 1-signal transducer and activator of transcription 3-suppressor of cytokine signaling 3 pathway.
Takahashi Y; Takahashi M; Carpino N; Jou ST; Chao JR; Tanaka S; Shigeyoshi Y; Parganas E; Ihle JN
Mol Endocrinol; 2008 Jul; 22(7):1673-81. PubMed ID: 18451094
[TBL] [Abstract][Full Text] [Related]
18. Nitidine chloride inhibits hepatocellular carcinoma cell growth in vivo through the suppression of the JAK1/STAT3 signaling pathway.
Liao J; Xu T; Zheng JX; Lin JM; Cai QY; Yu DB; Peng J
Int J Mol Med; 2013 Jul; 32(1):79-84. PubMed ID: 23613111
[TBL] [Abstract][Full Text] [Related]
19. CUEDC2 (CUE domain-containing 2) and SOCS3 (suppressors of cytokine signaling 3) cooperate to negatively regulate Janus kinase 1/signal transducers and activators of transcription 3 signaling.
Zhang WN; Wang L; Wang Q; Luo X; Fang DF; Chen Y; Pan X; Man JH; Xia Q; Jin BF; Li WH; Li T; Liang B; Chen L; Gong WL; Yu M; Li AL; Zhou T; Li HY
J Biol Chem; 2012 Jan; 287(1):382-392. PubMed ID: 22084247
[TBL] [Abstract][Full Text] [Related]
20. Lycopene treatment inhibits activation of Jak1/Stat3 and Wnt/β-catenin signaling and attenuates hyperproliferation in gastric epithelial cells.
Park B; Lim JW; Kim H
Nutr Res; 2019 Oct; 70():70-81. PubMed ID: 30098838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
